Sumitomo Life’s capitalisation to remain solid despite rising investment risks: S&P

S&P affirms A+ ratings, taking into account 2024 acquisition of Singapore Life and changes in asset allocation.

Share

Sumitomo lifes capitalisation to remain solid despite rising investment risks sp

THIS PREMIUM INSIGHT IS FOR SUBSCRIBERS ONLY.


Stay ahead with precise, independent journalism of APAC's insurance markets.

Unlocked access today:

Already subscribed? Log in using the form below or click here

Read next

Share this article